or
Bookmark and Share
   
Document Number
US Patent 6440930
Issued Date
August 27, 2002
Link
Inventors
Map
Abstract
The present invention discloses a stable, soluble formulation comprising a medically useful peptide or protein, a hydrophobic preservative, and nicotinamide. Said storage-stable, soluble formulation is useful as a multi-use pharmaceutical product.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
21
Comments:
no comments yet
Owner
Eli Lilly and Company (Indianapolis, IN)
Published
August 27, 2002
Application Number
09/787,500
Filed
March 16, 2001
US Classification
514/2   514/356
Int'l Classification
A61K   38/26   (20060101)  
Attorney/Law Firm
Parent Case
This is a 371 of PCT/US99/21055 filed Sep. 14, 1998 which claims the benefit of U.S. Provisional Application No. 60/100,687 filed Sep. 17, 1998. FIELD OF INVENTION
USPTO Field of Search
514/2   514/356  
Related Patents
7446090 - FSH formulation - Owned by Ares Trading S.A. (Aubonne,CH)

This invention relates to FSH or a FSH variant containing an alpha and beta subunit contained in formulations, and articles of manufacture. The invention provides advantageous new proteins and nucleic acids, multi-use pharmaceutical solutions, formulations and products of said proteins and nucleic acids where none approved for commercial use had previously existed having such extended use indications. These products are particularly useful in therapeutic regimens for increasing serum levels of FSH or a FSH variant over a period of treatment. Thus, inter alia, the invention fills the need for convenient products of FSH or from a FSH variant.

7563763 - FSH and FSH variant formulations, products and methods - Owned by Ares Trading S.A. (Aubonne,CH)

This invention relates to FSH or a FSH variant containing an alpha and beta subunit contained in formulations, and articles of manufacture. The invention provides advantageous new proteins and nucleic acids, multi-use pharmaceutical solutions, formulations and products of said proteins and nucleic acids where none approved for commercial use had previously existed having such extended use indications. These products are particularly useful in therapeutic regimens for increasing serum levels of FSH or a FSH variant over a period of treatment. Thus, inter alia, the invention fills the need for convenient products of FSH or from a FSH variant.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us